ALPS Group Inc
ALPSHealthcare·Biotechnology·Malaysia·Nano·NASD·Nov 11 • 3:13 PM ET
1.15-0.45 (-28.29%)
2026-11-11 21:13 CET
Market cap
53.25 USD m
Revenue, TTM
4.86 USD m
Net income, TTM
-2.01 USD m
Free cash flow, TTM
-2.68 USD m
EPS diluted, TTM
-0.06
P/E
-
Price
ALPS against its 20, 50 and 200-day averages2050200
86.7% under the 52-week high of 8.60 on 28 Nov 2025. 52-week low 1.03 on 11 Nov 2026. Last 15 sessions, 96.1% high to low
Volume 10.34× normal · the line is the 50-bar volume average
Profile
ALPS52-week range, 0% of the way up
1.158.60
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.
| Employees | 89 |
|---|---|
| IPO | Dec 23, 2021 |
| Beta | -0.68 |
| ATR, 14d | 0.13 |
| Rel volume | 10.34 |
| Short float | 0.17% |
| Insider own | 70.90% |
| Inst own | 1.63% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 36.35M |
| Enterprise Value | 41.90M |
| Income | -2.73M |
| Sales | 0.00M |
| Book/sh | -15.96 |
| Cash/sh | 0.01 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | Feb 13, 2023 |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 89 |
| IPO | Dec 23, 2021 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | - |
| P/B | - |
| P/C | 100.98 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | - |
| Quick Ratio | 0.04 |
| Current Ratio | 0.04 |
| Debt/Eq | - |
| LT Debt/Eq | - |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | -3.63 |
|---|---|
| EPS next Y | - |
| EPS next Q | - |
| EPS this Y | - |
| EPS next Y | - |
| EPS next 5Y | - |
| EPS past 3/5Y | - -11.49% |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | -3454.31% |
| Sales Y/Y TTM | - |
| EPS Q/Q | -5969.59% |
| Sales Q/Q | - |
| Earnings | Aug 07 BMO |
| EPS/Sales Surpr. | - - |
Ownership
| Insider Own | 70.90% |
|---|---|
| Insider Trans | 0.00% |
| Inst Own | 1.63% |
| Inst Trans | 3.69% |
| ROA | -17.24% |
| ROE | -62.50% |
| ROIC | - |
| Gross Margin | - |
| Oper. Margin | - |
| Profit Margin | - |
| SMA20 | -28.84% |
| SMA50 | -36.42% |
| SMA200 | -64.81% |
| Trades | - |
Technical
| Shs Outstand | 33.28M |
|---|---|
| Shs Float | 9.69M |
| Short Float | 0.17% |
| Short Ratio | 1.17 |
| Short Interest | 0.02M |
| 52W High | 8.60 -86.66% |
| 52W Low | 1.15 0.10% |
| Volatility | 8.09% 4.11% |
| ATR (14) | 0.13 |
| RSI (14) | 14.80 |
| Beta | -0.68 |
| Rel Volume | 10.34 |
| Avg Volume | 14.11K |
| Volume | 129,165 |
Performance
| Perf Week | -28.29% |
|---|---|
| Perf Month | -34.43% |
| Perf Quarter | -30.04% |
| Perf Half Y | -72.68% |
| Perf YTD | -73.60% |
| Perf Year | -61.86% |
| Perf 3Y | -97.88% |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | - |
| Target Price | - |
| Prev Close | 1.60 |
| Price | 1.15 |
| Change % | -28.29% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| CSBR | Champions Oncology Inc | 65.14M |
| BNR | Burning Rock Biotech Ltd ADR | 113.30M |
| LGVN | Longeveron Inc | 10.36M |
| FLGT | Fulgent Genetics Inc | 708.54M |
| BRTX | BioRestorative Therapies Inc | 2.12M |
| PRPO | Precipio Inc | 44.80M |
| ADVB | Advanced Biomed Inc | 3.71M |
| BGLC | BioNexus Gene Lab Corp | 2.76M |
| SBC | SBC Medical Group Holdings Inc | 535.83M |
| PRE | Prenetics Global Limited | 299.46M |
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| EPS, annual | -0.008 | 0.015 | 0.144 | -0.167 | -0.062 | |||
|---|---|---|---|---|---|---|---|---|
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | |||
| EPS, quarterly | 0.031 | 0.016 | -0.063 | -0.036 | -0.019 | -0.049 | -0.992 | -1.178 |
| Period | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 |
| Sales, annual | 0 | 0 | 0 | 0 | 4.856 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | |||
| Sales, quarterly | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 |
| Shares, annual | 14.945 | 14.945 | 6.008 | 3.723 | 33.28 | |||
| Period | 2021 | 2022 | 2023 | 2024 | 2025 | |||
| Shares, quarterly | 8.188 | 6.008 | 6.008 | 6.008 | 6.008 | 3.723 | 0.745 | 0.704 |
| Period | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Total Revenue | 4.86 | 4.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 4.43 | 4.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.43 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 3.74 | 3.74 | 1.57 | 0.99 | 1.11 | 0.14 |
| Research and Development | 0.06 | 0.06 | - | - | - | - |
| Other Operating Expense | 0.07 | 0.07 | 0.27 | 0.20 | 0.15 | 0.00 |
| Operating Income | -3.38 | -3.38 | -1.83 | -1.19 | -1.26 | -0.14 |
| Non-Operating Income (Expense) | 0.28 | 0.28 | 1.29 | 3.09 | 1.68 | 0.00 |
| Interest Expense | 0.05 | 0.05 | 0.19 | 0.06 | 0.00 | 0.00 |
| Unusual Expense | -1.06 | -1.06 | 0.00 | -0.00 | -0.11 | -0.02 |
| Net Income Before Taxes | -2.08 | -2.08 | -0.74 | 1.85 | 0.53 | -0.12 |
| Income Taxes | 0.01 | 0.01 | 0.24 | 0.53 | 0.31 | 0.00 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -2.09 | -2.09 | -0.98 | 1.32 | 0.22 | -0.12 |
| Net Income From Continuing Operations | -2.01 | -2.01 | -0.98 | 1.32 | 0.22 | -0.12 |
| Net Income | -2.01 | -2.01 | -0.98 | 1.32 | 0.22 | -0.12 |
| EPS (Recurring) | -0.08 | -0.08 | -0.17 | 0.14 | 0.01 | -0.01 |
| EPS (Basic, Before Extraordinaries) | -0.06 | -0.06 | -0.17 | 0.14 | 0.01 | -0.01 |
| EPS (Diluted) | -0.06 | -0.06 | -0.17 | 0.14 | 0.01 | -0.01 |
| EBITDA | -2.25 | -2.25 | -1.83 | -1.19 | -1.26 | -0.14 |
| Price To Sales Ratio | - | 33.44 | - | - | - | - |
| Gross Margin | - | 8.83 | - | - | - | - |
| Operating Margin | - | -69.51 | - | - | - | - |
| Net Margin | - | -41.36 | - | - | - | - |
| Shares Outstanding | 0.70 | 33.28 | 3.72 | 6.01 | 14.95 | 14.95 |
| Market Capitalization | 53.25 | 53.25 | 3.42 | - | - | - |
Income statement, quarterly
| Metric | 2025Q2 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 0.30 | 0.33 | 0.27 | 0.26 | 0.29 | 0.42 | 0.60 | 0.28 |
| Other Operating Expense | 0.15 | 0.12 | 0.21 | 0.17 | 0.05 | 0.05 | -0.00 | 0.05 |
| Operating Income | -0.45 | -0.45 | -0.48 | -0.43 | -0.34 | -0.47 | -0.60 | -0.33 |
| Interest Expense | 0.39 | 0.45 | 0.29 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 |
| Unusual Expense | 0.01 | 0.02 | 0.00 | -0.01 | -0.01 | 0.01 | 0.01 | -0.01 |
| Net Income Before Taxes | -0.84 | -0.89 | -0.74 | -0.23 | -0.03 | -0.18 | -0.30 | 0.20 |
| Income Taxes | -0.01 | 0.01 | 0.00 | 0.04 | 0.09 | 0.03 | 0.07 | 0.10 |
| Consolidated Net Income | -0.83 | -0.89 | -0.74 | -0.27 | -0.12 | -0.22 | -0.38 | 0.10 |
| Net Income From Continuing Operations | -0.83 | -0.89 | -0.74 | -0.27 | -0.12 | -0.22 | -0.38 | 0.10 |
| Net Income | -0.83 | -0.89 | -0.74 | -0.27 | -0.12 | -0.22 | -0.38 | 0.10 |
| EPS (Recurring) | -1.17 | -1.20 | -0.99 | -0.05 | -0.02 | -0.03 | -0.06 | 0.01 |
| EPS (Basic, Before Extraordinaries) | -1.18 | -1.22 | -0.99 | -0.05 | -0.02 | -0.04 | -0.06 | 0.02 |
| EPS (Diluted) | -1.18 | -1.22 | -0.99 | -0.05 | -0.02 | -0.04 | -0.06 | 0.02 |
| EBITDA | -0.45 | -0.45 | -0.48 | -0.43 | -0.34 | -0.47 | -0.60 | -0.33 |
| Non-Operating Income (Expense) | 0.01 | 0.03 | 0.03 | 0.25 | 0.35 | 0.34 | 0.34 | 0.54 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 0.70 | 0.70 | 0.74 | 3.72 | 6.01 | 6.01 | 6.01 | 6.01 |
| Market Capitalization | 53.25 | - | - | - | - | - | - | - |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|
| Cash & Short Term Investments | 0.61 | 0.25 | 0.08 | 0.08 | 0.81 |
| Short Term Receivables | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.39 | 0.10 | 0.13 | 0.21 | 0.22 |
| Total Current Assets | 1.97 | 0.35 | 0.20 | 0.29 | 1.03 |
| Net Property, Plant & Equipment | 2.69 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 1.68 | 3.35 | 28.67 | 118.41 | 116.73 |
| Intangible Assets | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | - | 0.56 | 0.36 | 0.08 | - |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 |
| Total Assets | 6.97 | 4.26 | 29.24 | 118.78 | 117.96 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.38 | 4.45 | 1.76 | 0.00 | 0.00 |
| Accounts Payable | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Tax Payable | 0.00 | 0.48 | 0.53 | 0.23 | - |
| Other Current Liabilities | 4.74 | 2.21 | 1.88 | 0.55 | 0.23 |
| Total Current Liabilities | 5.48 | 7.14 | 4.17 | 0.78 | 0.23 |
| Long Term Debt | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 0.02 | 0.56 | 0.36 | 0.16 | - |
| Other Liabilities | 4.52 | 4.03 | 4.03 | 4.03 | 4.14 |
| Total Liabilities | 10.20 | 11.73 | 8.56 | 4.97 | 4.37 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -2.92 | -7.46 | 20.67 | 113.81 | 113.59 |
| Total Shareholders Equity | -2.92 | -7.46 | 20.67 | 113.81 | 113.59 |
| Accumulated Minority Interest | -0.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | -3.23 | -7.46 | 20.67 | 113.81 | 113.59 |
| Total Liabilities & Stockholders Equity | 6.97 | 4.26 | 29.24 | 118.78 | 117.96 |
| Book Value Per Share | -0.09 | -2.00 | 3.44 | 7.62 | 7.60 |
| Tangible Book Value Per Share | -0.11 | -2.00 | 3.44 | 7.62 | 7.60 |
| Full-Time Employees | 89 | 2 | 2 | - | - |
| Price to Book Ratio | -0.10 | -0.30 | - | - | - |
| Return on Assets | -35.76 | -5.84 | 1.78 | 0.19 | - |
| Return on Equity | - | -14.81 | 1.96 | 0.20 | - |
| Return on Invested Capital | - | - | 6.39 | 0.20 | -0.11 |
| Quick Ratio | 0.27 | 0.05 | 0.05 | 0.37 | 4.46 |
| Current Ratio | 0.36 | 0.05 | 0.05 | 0.37 | 4.46 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY |
|---|---|---|---|---|---|---|
| Net Income | -2.08 | -2.08 | -0.98 | 1.32 | 0.22 | -0.12 |
| Depreciation | 1.13 | 1.13 | - | - | - | - |
| Deferred Taxes & Investment Tax Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Funds (Non Cash) | -0.99 | -0.99 | -1.28 | -3.09 | -1.79 | -0.02 |
| Funds from Operations | -1.94 | -1.94 | -2.26 | -1.77 | -1.57 | -0.14 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.69 | -0.69 | 0.22 | 0.37 | 0.84 | -0.19 |
| Income Taxes Payable | - | - | -0.05 | 0.30 | 0.23 | 0.08 |
| Cash from Operating Activities | -2.63 | -2.63 | -2.04 | -1.40 | -0.73 | -0.32 |
| Capital Expenditures | -0.06 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -0.01 | -0.01 | -0.29 | -0.69 | 0.00 | -116.72 |
| Purchase of Investments | -0.01 | -0.01 | -0.72 | -1.23 | 0.00 | -116.72 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.43 | 0.54 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 26.89 | 93.52 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.06 | -0.06 | 26.60 | 92.83 | 0.00 | -116.72 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 3.11 | 3.11 | -26.89 | -93.52 | 0.00 | 117.86 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | -26.89 | -93.52 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 3.11 | 3.11 | 0.00 | 0.00 | 0.00 | 117.86 |
| Proceedsfrom Stock Options | 3.11 | 3.11 | 0.00 | 0.00 | 0.00 | 117.86 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 2.50 | 1.70 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.28 | 0.28 | 0.00 | 0.39 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 |
| Cash from Financing Activities | 2.98 | 2.98 | -24.39 | -91.43 | 0.00 | 117.86 |
| Exchange Rate Effect | -0.00 | -0.00 | - | - | - | - |
| Net Change in Cash | 0.29 | 0.29 | 0.17 | -0.00 | -0.73 | 0.81 |
| Free Cash Flow | -2.68 | -2.68 | -2.04 | -1.40 | -0.73 | -0.32 |
Balance sheet, quarterly
| Metric | 2025Q2 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 0.36 | 2.62 | 0.00 | 0.25 | 0.07 | 0.14 |
| Short Term Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.01 | 0.05 | 0.05 | 0.10 | 0.06 | 0.14 |
| Total Current Assets | 0.36 | 2.66 | 0.05 | 0.35 | 0.13 | 0.28 |
| Net Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Investments and Advances | 1.38 | 1.13 | 3.56 | 3.35 | 29.81 | 29.28 |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | - | - | - | 0.56 | - | - |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 1.74 | 3.80 | 3.62 | 4.26 | 29.94 | 29.56 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.91 | 5.08 | 4.21 | 4.45 | 3.74 | 3.38 |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Tax Payable | 0.52 | 0.52 | 0.48 | 0.48 | 0.44 | 0.35 |
| Other Current Liabilities | 2.49 | 4.92 | 2.16 | 2.21 | 1.76 | 1.70 |
| Total Current Liabilities | 8.92 | 10.52 | 6.85 | 7.14 | 5.93 | 5.43 |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | - | - | - | 0.56 | - | - |
| Other Liabilities | 4.05 | 4.05 | 4.03 | 4.03 | 4.04 | 4.05 |
| Total Liabilities | 12.97 | 14.57 | 10.88 | 11.73 | 9.97 | 9.48 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -11.23 | -10.77 | -7.26 | -7.46 | 19.97 | 20.08 |
| Total Shareholders Equity | -11.23 | -10.77 | -7.26 | -7.46 | 19.97 | 20.08 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | -11.23 | -10.77 | -7.26 | -7.46 | 19.97 | 20.08 |
| Total Liabilities & Stockholders Equity | 1.74 | 3.80 | 3.62 | 4.26 | 29.94 | 29.56 |
| Book Value Per Share | -15.96 | -15.32 | -9.75 | -2.00 | 3.32 | 3.34 |
| Tangible Book Value Per Share | -15.96 | -15.32 | -9.75 | -2.00 | 3.32 | 3.34 |
| Full-Time Employees | - | - | - | 2 | - | - |
| Price to Book Ratio | -0.10 | - | - | - | - | - |
| Return on Assets | -17.24 | -12.10 | -8.18 | -5.84 | -1.51 | -0.60 |
| Return on Equity | -62.50 | -43.37 | -20.58 | -14.81 | -1.91 | -0.76 |
| Return on Invested Capital | - | - | - | - | -0.58 | -1.08 |
| Quick Ratio | 0.04 | 0.25 | 0.01 | 0.05 | 0.02 | 0.05 |
| Current Ratio | 0.04 | 0.25 | 0.01 | 0.05 | 0.02 | 0.05 |
Cash flow, quarterly
| Metric | 2025Q2 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 |
|---|---|---|---|---|---|---|
| Net Income | -0.83 | -0.89 | -0.74 | -0.27 | -0.12 | -0.22 |
| Other Funds (Non Cash) | 0.32 | 0.37 | 0.19 | -0.26 | -0.36 | -0.33 |
| Funds from Operations | -0.51 | -0.52 | -0.55 | -0.53 | -0.48 | -0.55 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.26 | 0.25 | 0.39 | 0.25 | 0.28 | -0.13 |
| Income Taxes Payable | -0.01 | 0.04 | 0.00 | 0.09 | 0.14 | -0.21 |
| Cash from Operating Activities | -0.25 | -0.27 | -0.16 | -0.28 | -0.20 | -0.67 |
| Capital Expenditures | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 2.37 | -0.13 | -0.18 | -0.18 | -0.18 | 0.25 |
| Purchase of Investments | -0.43 | -0.13 | -0.18 | -0.18 | -0.18 | -0.18 |
| Sale Or Maturity of Investments | 2.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 26.89 | 0.00 | -0.14 |
| Cash from Investing Activities | 2.37 | -0.13 | -0.18 | 26.71 | -0.18 | 0.11 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | -2.62 | 0.00 | 0.00 | -26.89 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | -2.62 | 0.00 | 0.00 | -26.89 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.44 | 0.42 | 0.03 | 0.65 | 0.30 | 0.70 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.40 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | - | - | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | -1.78 | 0.42 | 0.09 | -26.24 | 0.30 | 0.70 |
| Net Change in Cash | 0.34 | 0.02 | -0.25 | 0.19 | -0.08 | 0.14 |
| Free Cash Flow | -0.25 | -0.27 | -0.16 | -0.28 | -0.20 | -0.67 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.17% | 0.0M | 9.7M | 11.03K |
| 2026-10-15 | 0.25% | 0.0M | 9.7M | 12.00K |
| 2026-09-30 | 0.26% | 0.0M | 9.7M | 25.38K |
| 2026-09-15 | 0.26% | 0.0M | 9.7M | 25.75K |
| 2026-08-31 | 0.07% | 0.0M | 9.7M | 24.75K |
| 2026-08-14 | 0.05% | 0.0M | 9.7M | 23.08K |
| 2026-07-31 | 0.04% | 0.0M | 9.0M | 22.04K |
| 2026-07-15 | 0.07% | 0.0M | 9.0M | 20.71K |
| 2026-06-30 | 0.03% | 0.0M | 9.0M | 6.29K |
| 2026-06-15 | 0.05% | 0.0M | 9.0M | 4.59K |
| 2026-05-29 | 0.01% | 0.0M | 9.0M | 5.75K |
| 2026-05-15 | 0.01% | 0.0M | 9.0M | 5.68K |
| 2026-04-30 | 0.07% | 0.0M | 9.0M | 5.73K |
| 2026-04-15 | 0.08% | 0.0M | 9.0M | 7.12K |
| 2026-03-31 | 0.07% | 0.0M | 9.0M | 9.45K |
| 2026-03-13 | 0.08% | 0.0M | 9.0M | 10.47K |
| 2026-02-27 | 0.22% | 0.0M | 9.0M | 12.70K |
| 2026-02-13 | 0.26% | 0.0M | 9.0M | 23.21K |
| 2026-01-30 | 0.20% | 0.0M | 9.0M | 83.80K |
| 2026-01-15 | 0.22% | 0.0M | 9.0M | 92.73K |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-30 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-30 | SEC |
| 2026-10-15 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-15 | SEC |
| 2026-10-08 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-08 | SEC |
| 2026-08-07 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-08-07 | SEC |
| 2026-08-06 | 20-F | Registration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer. | 2026-03-31 | SEC |
| 2026-07-31 | NT 20-F | 2026-03-31 | SEC | |
| 2026-06-23 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-23 | SEC |
| 2026-06-09 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-09 | SEC |
| 2026-05-19 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-05-19 | SEC |
| 2026-04-20 | 3 | Initial statement of beneficial ownership of securities | 2026-04-17 | SEC |
| 2026-04-17 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-04-17 | SEC |
| 2026-03-24 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-24 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-24 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-24 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-20 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-20 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-20 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-20 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-02-23 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-02-23 | SEC |
| 2026-02-05 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-02-04 | SEC |
| 2026-01-30 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-01-30 | SEC |
| 2026-01-21 | 424B3 | SEC | ||
| 2026-01-20 | EFFECT | Effectiveness filing by commission order | SEC | |
| 2026-01-15 | CORRESP | SEC | ||
| 2026-01-14 | UPLOAD | Upload Submission | SEC | |
| 2026-01-08 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-01-08 | SEC |
| 2026-01-07 | F-1 | Registration statement for certain foreign private issuers | SEC | |
| 2025-11-12 | SCHEDULE 13D | SEC | ||
| 2025-11-03 | SCHEDULE 13G | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| MILLENNIUM MANAGEMENT LLC | 0.22% |
| MMCAP International Inc. SPC | 0.03% |
| CITADEL ADVISORS LLC | 0.03% |
| Diversified Trust Co | 0.02% |
| JONES FINANCIAL COMPANIES LLLP | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.01% |
| ARISTEIA CAPITAL, L.L.C. | 0.01% |
| SkyView Investment Advisors, LLC | 0.01% |
| UBS Group AG | 0.00% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Nasdaq Composite Index Fund | 0.01% |
OakChart. ALPS. Cached 15 minutes.
Some panels did not load: ratings, insider, news.